tradingkey.logo

Sana Biotechnology Inc <SANA.OQ> expected to post a loss of 23 cents a share - Earnings Preview

ReutersMay 2, 2025 11:18 AM
  • Sana Biotechnology Inc SANA.OQ SANA.O is expected to show no change in quarterly revenue when it reports results on May 6 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Sana Biotechnology Inc is for a loss of 23 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Sana Biotechnology Inc is $9.00​, above​ its last closing price of $1.90. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.23

-0.21

Beat

7.2

Sep. 30 2024

-0.25

-0.25

-0.25

Met

-0.1

Jun. 30 2024

-0.28

-0.28

-0.21

Beat

26.3​

Mar. 31 2024

-0.33

-0.32

-0.49

Missed

-54.1

​​Dec. 31 2023

-0.38

-0.38

-0.41

Missed

-7.9

Sep. 30 2023

-0.43

-0.45

0.02

Beat

104.5​

Jun. 30 2023

-0.42

-0.43

-0.59

Missed

-38.3

Mar. 31 2023

-0.42

-0.45

-0.43

Beat

3.7

This summary was machine generated May 2 at 11:18 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI